Recent patient data surrounding this compound, specifically the 120mg formulation branded as ZPHC, indicate a considerable effect on body mass loss and associated chronic illnesses . Researchers believe that this dual compound, influencing both GLP-1 and GIP pathways , could offer a noteworthy improvement in the treatment of excess weight and relat